NAMI

Jinxin Technology Holding Company

NAMIADR

Q3 2026 funds3 buying0 selling

NAMI institutional ownership changes in Q3 2026: 3 institutions opened or added positions, 0 trimmed or exited. NAMI (Jinxin Technology Holding Company) is held by 3 institutional investors as of Q3 2026. Top institutional shareholders: Jane Street Group, LLC ($54,459), UBS Group AG ($2,547), JPMorgan Chase & Co. ($13). Institutions were buying, on balance.

NAMI

Smart Money Verdict

View all
Loading verdict
Held by 3 funds

Who's Trading

Source dates: Price Nov 13, 2026 · Insiders Jul 6, 2026 · Activists Oct 30, 2026 · Congress none

ActivistWUWU CAPITAL LTD0.0%
InsiderJJJiang Jun JasonSell $915.5
InsiderJJJiang Jun JasonSell $4K
Checking access…

Top Holders

Fund ownership
Fund holdings as of
Funds holding3
avg
Value of reported holdings$57,019
Funds buying / selling
3opened or added
0reduced or exited
100% buying consensus
Checking access…
Action
New
23,174$54,4590.0%-31.06%
32
New
1,084$2,5470.0%-31.06%
19
New
5$130.0%-31.06%
17
Latest insider trades
InsiderTradeTraded
Jiang Jun JasonSell $915.5
Jiang Jun JasonSell $4K
Jiang Jun JasonSell $2K
Jiang Jun JasonSell $921.25
Jiang Jun JasonSell $4K
Jiang Jun JasonSell $8K
Jiang Jun JasonSell $2K
Jiang Jun JasonSell $2K
Jiang Jun JasonSell $8K
Jiang Jun JasonSell $985
Loading Congress trades…
Latest activist filings
FilerStakeFiled
WU CAPITAL LTD0.0%
NAMINAMIJinxin Technology Holding Company

Questions investors ask about NAMI

Who owns NAMI?

3 institutional investors held NAMI on September 30, 2026, led by Jane Street Group, LLC ($54,459), UBS Group AG ($2,547) and JPMorgan Chase & Co. ($13).

How many hedge funds hold NAMI?

3 institutional investors reported NAMI in their 13F filings for the quarter ended September 30, 2026, $57,019 in all.

Are institutions buying or selling NAMI?

Buying, on balance. In Q3 2026, 3 institutions opened or added to positions in NAMI and 0 institutions trimmed or exited.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Optional analytics helps us improve. How it’s used